PBLS Parabilis Medicines, Inc.
Price Chart
Executive Summary
RA Capital Management, a director and 10% owner, purchased 19.73M shares of PBLS for $394.57M at $20/share on June 11, representing ~13% of market cap. Director Alan Sebulsky also bought ~$613K in open-market purchases. This cluster coincides with the company's IPO and a $75M Regeneron private placement disclosed in a June 11 8-K, signaling strong insider conviction.
Key Financial Metrics
Actionable Insight
The massive insider buy by RA Capital at $20/share, aligned with the IPO and Regeneron investment, is a powerful vote of confidence. Monitor for price discovery above $20 as the market absorbs this signal. Watch for lockup expiration details from the IPO for potential selling pressure.
Key Facts
- RA Capital Management purchased 19,728,353 shares at $20.00 for $394.57M on June 11, 2026
- Alan Sebulsky (Director) purchased 25,935 shares total (~$613K) across three open-market buys on June 11, 12, and 15
- Total insider buying of ~$395.2M represents ~13.2% of PBLS's $3.0B market cap
- Non-cash derivative conversions by RA Capital, Edward Fitzgerald, and James Flynn had no economic impact
- Cluster coincides with June 11 8-K detailing IPO completion and $75M Regeneron private placement
Financial Impact
$394.57M insider purchase by RA Capital, ~13% of market cap; Sebulsky added ~$613K
Risk Factors
- IPO lockup expiration could introduce selling pressure from other pre-IPO holders
- Governance changes (classified board, supermajority votes) may deter some institutional investors
- Stock is thinly traded post-IPO; large insider position may limit liquidity
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PBLS-1781648407180 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 16, 2026
4d ago
|
Insider Cluster
| $26.03 $25.85 | ▼ −0.69% | ▼ −1.47% | $25.85 (−0.69%) |
|
Jun 15, 2026
5d ago
|
Insider Cluster
| $26.59 $26.03 | ▼ −2.11% | ▼ −0.86% | $25.85 (−2.78%) |
|
Jun 11, 2026
9d ago
|
8-K
| $27.26 $25.01 | ▼ −8.25% | ▼ −10.02% | $25.85 (−5.17%) |
|
Jun 10, 2026
10d ago
|
424B4
| $30.31 $27.26 | ▼ −10.06% | ▼ −10.60% | $25.85 (−14.71%) |
|
Jun 10, 2026
11d ago
|
EFFECT
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access